Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...

Research highlights the therapeutic potential of targeting cannabinoid receptors to counter memory impairment in early ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

The newly approved medicines in 2024 from Massachusetts companies range from a schizophrenia drug to a gene therapy for ...

Among the many FDA decisions in 2024, some stood out more than others. Among the approvals were some surprising—and not-so surprising—complete response letters (CRLs). In addition, some ...

TETANUS toxin is thought to act by suppressing synaptic inhibition 1, and presumably it acts upon some substance at the inhibitory synapses in the grey matter of nervous tissue. As a possible ...

Cell-surface receptors are crucial for cells to sense and respond to the environment. After binding to a specific chemical outside the cell, the membrane-spanning proteins trigger signalling ...

Traditional therapies targeting androgen receptor (AR) signaling have limited efficacy. In a recent study, researchers investigated the potential of azolato-bridged dinuclear platinum(II ...

The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, State Key Laboratory of Physical Chemistry of Solid Surfaces, Department of Chemistry, College of Chemistry and Chemical ...

2001). Bethanechol, a direct-acting muscarinic receptor agonist, has been used in the past as a promotility agent for treating GERD. This drug acts by mimicking the effect of ACh directly at the ...